These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 16678040

  • 1. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M, Stypmann J, Bruch C, Wichter T, Hoppe M, Drees G, Berendes E, Huelsken G, Loeher A, Welp H, Röttger C, Schmid C, Scheld HH, Tjan TD.
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 May; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 4. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M, Wichter T, Schmid C, Stypmann J, Tjan TD, Berendes E, Etz C, Pioux A, Löher A, Wenzelburger F, Drees G, Hoffmeier A, Breithardt G, Scheld HH.
    J Heart Lung Transplant; 2004 Oct 18; 23(10):1189-97. PubMed ID: 15477114
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec 18; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 10. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.
    Clin Biochem; 2006 Jun 18; 39(6):640-5. PubMed ID: 16516185
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
    Tang WH, Steinhubl SR, Van Lente F, Brennan D, McErlean E, Maroo A, Francis GS, Topol EJ.
    Am Heart J; 2007 Jan 18; 153(1):36-41. PubMed ID: 17174634
    [Abstract] [Full Text] [Related]

  • 16. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP.
    J Am Coll Cardiol; 2005 May 17; 45(10):1667-71. PubMed ID: 15893185
    [Abstract] [Full Text] [Related]

  • 17. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
    J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
    [Abstract] [Full Text] [Related]

  • 18. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U, Albåge A, Larsson PT, Insulander P, Lindblom D.
    Eur J Cardiothorac Surg; 2007 May 23; 31(5):922-8. PubMed ID: 17321144
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E, PEACE Investigators.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):205-14. PubMed ID: 17631211
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.